BR0110402A - Compostos - Google Patents

Compostos

Info

Publication number
BR0110402A
BR0110402A BR0110402-0A BR0110402A BR0110402A BR 0110402 A BR0110402 A BR 0110402A BR 0110402 A BR0110402 A BR 0110402A BR 0110402 A BR0110402 A BR 0110402A
Authority
BR
Brazil
Prior art keywords
polypeptides
polynucleotides
compounds
genes
compost
Prior art date
Application number
BR0110402-0A
Other languages
English (en)
Inventor
Pankaj Agarwal
Paul R Murdock
Safia K Rizvi
Randall F Smith
Zhaoying Xiang
Karen S Kabnich
Ying-Ta Lai
Qing Xie
Original Assignee
Smithkline Beecham Corp
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp, Smithkline Beecham Plc filed Critical Smithkline Beecham Corp
Publication of BR0110402A publication Critical patent/BR0110402A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Psychology (AREA)
  • Biophysics (AREA)

Abstract

"COMPOSTOS". São descritos polipeptídeos e polinucleotídeos dos genes apresentados na Tabela I e processo para a produção de tais polipeptídeos por técnicas recombinantes. Também descritos são processos para a utilização de polipeptídeos e polinucleotídeos dos genes apresentados na Tabela I em testes diagnósticos.
BR0110402-0A 2000-04-27 2001-04-26 Compostos BR0110402A (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US19996300P 2000-04-27 2000-04-27
US20333600P 2000-05-11 2000-05-11
US20708700P 2000-05-25 2000-05-25
US20754600P 2000-05-26 2000-05-26
PCT/US2001/013360 WO2001081363A1 (en) 2000-04-27 2001-04-26 Novel compounds

Publications (1)

Publication Number Publication Date
BR0110402A true BR0110402A (pt) 2003-02-11

Family

ID=27498358

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0110402-0A BR0110402A (pt) 2000-04-27 2001-04-26 Compostos

Country Status (15)

Country Link
EP (1) EP1276755A4 (pt)
JP (1) JP2003530869A (pt)
KR (1) KR20030032940A (pt)
CN (1) CN1439017A (pt)
AU (1) AU2001257265A1 (pt)
BR (1) BR0110402A (pt)
CA (1) CA2407449A1 (pt)
CZ (1) CZ20023548A3 (pt)
HK (1) HK1053840A1 (pt)
HU (1) HUP0300595A3 (pt)
IL (1) IL152416A0 (pt)
MX (1) MXPA02010692A (pt)
NO (1) NO20025151L (pt)
PL (1) PL358580A1 (pt)
WO (1) WO2001081363A1 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6558936B1 (en) * 1999-10-01 2003-05-06 Millennium Pharmaceuticals, Inc. Human lipase proteins, nucleic acids encoding them, and uses of both of these
US6630335B1 (en) 2000-02-11 2003-10-07 Millennium Pharmaceuticals, Inc. 14171 protein kinase, a novel human protein kinase and uses thereof
NZ523122A (en) * 2000-06-22 2004-06-25 Smithkline Beecham Corp Polypeptides and polynucleotides and methods of identifying agonists and antagonists in relation to treatment of diseases
EP1294883A2 (en) * 2000-06-30 2003-03-26 Incyte Genomics, Inc. Human extracellular matrix (ecm)-related tumor marker
WO2002012330A2 (en) * 2000-08-04 2002-02-14 Zymogenetics, Inc. Human secreted protein, zzp1
US7358353B2 (en) 2000-08-22 2008-04-15 Agensys, Inc. Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
WO2002016598A2 (en) 2000-08-22 2002-02-28 Agensys, Inc. Nucleic acid and corresponding protein named 158p1h4 useful in the treatment and detection of bladder and other cancers
WO2002026826A2 (en) * 2000-09-27 2002-04-04 Curagen Corporation Proteins and nucleic acids encoding same
US6875570B2 (en) 2000-09-27 2005-04-05 Curagen Corporation Proteins and nucleic acids encoding same
US20020151695A1 (en) * 2000-11-28 2002-10-17 Shuqian Jing Transforming growth factor-beta-related molecules and uses thereof
JP2004535161A (ja) 2001-03-08 2004-11-25 イミュネックス・コーポレーション ヒト・セルピン・ポリペプチド
US6921807B2 (en) 2001-03-29 2005-07-26 Zymogenetics, Inc. Proteinase inhibitor ZSERP9
US20020172995A1 (en) * 2001-05-17 2002-11-21 Wei Shao Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
AU2002318513A1 (en) * 2001-07-06 2003-01-21 Nsgene A/S Novel neurotrophic factors
US20030215852A1 (en) * 2002-04-01 2003-11-20 Wyeth Novel pancortin-Pablo protein interactions and methods of use thereof
EP2343315A3 (en) * 2003-02-10 2011-11-23 Agensys, Inc. Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
US7422906B2 (en) 2003-02-10 2008-09-09 Taisho Pharmaceutical Co., Ltd. Apoptosis-inducing gene and utilization of the same
WO2005012344A1 (en) * 2003-08-01 2005-02-10 Zymogenetics, Inc. Adipocyte complement related protein zacrp11
US7399469B2 (en) * 2004-03-26 2008-07-15 Pdl Biopharma, Inc. Anti-LFL2 antibodies for the diagnosis, prognosis and treatment of cancer
TR201900694T4 (tr) 2012-08-23 2019-02-21 Agensys Inc 158p1d7 proteinlerine bağlanan antikor ilaç konjugatları (adc).
EP3400068A1 (en) * 2016-01-06 2018-11-14 Yeda Research and Development Co., Ltd. Compositions and methods for treating malignant, autoimmune and inflammatory diseases
CN108178797B (zh) * 2017-12-29 2020-12-01 西南大学 一种抗家蚕BmSRC多克隆抗血清、制备方法及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995030428A1 (en) * 1994-05-05 1995-11-16 Human Genome Sciences, Inc. Human dnase
US5830744A (en) * 1995-06-06 1998-11-03 Human Genome Sciences, Inc. Gene encoding human Dnase
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides

Also Published As

Publication number Publication date
MXPA02010692A (es) 2003-03-10
JP2003530869A (ja) 2003-10-21
EP1276755A1 (en) 2003-01-22
CZ20023548A3 (cs) 2003-05-14
HUP0300595A2 (hu) 2003-06-28
KR20030032940A (ko) 2003-04-26
PL358580A1 (en) 2004-08-09
HK1053840A1 (zh) 2003-11-07
WO2001081363A1 (en) 2001-11-01
EP1276755A4 (en) 2004-03-31
CA2407449A1 (en) 2001-11-01
AU2001257265A1 (en) 2001-11-07
HUP0300595A3 (en) 2007-06-28
NO20025151D0 (no) 2002-10-25
NO20025151L (no) 2002-12-13
CN1439017A (zh) 2003-08-27
IL152416A0 (en) 2003-05-29

Similar Documents

Publication Publication Date Title
BR0110402A (pt) Compostos
BR0113820A (pt) Compostos
ATE299145T1 (de) Neues multimerisierendes reagenz
BR0111877A (pt) Compostos
DE69637726D1 (de) Gruppen zum einfangen von nukleinsäuren
DE69011189D1 (de) Treiber für Hochvolt-Halbbrücken-Schaltkreise.
DE59603145D1 (de) Vorrichtung zur Zugabe von Reinigungsmitteln, insbesondere für Geschirrspülmaschinen
DK1054860T3 (da) Proces for syntesen af 1,3-dioler
DE69402043T2 (de) Verfahrenshilfsmittel für gaserzeugende Zusammensetzungen
ATE373105T1 (de) Verbindungen und methoden zum nachweis von biomolekülen
DE69533564D1 (de) Effektor-Proteine für Rapamycin
DE69736840D1 (de) Synthese von nukleosiden und polynukleotiden
DK0815114T3 (da) Nucleinsyresyntese ved anvendelse af lysfraspaltelige beskyttende grupper
BR9400143A (pt) Processo de moldagem por injeção com reação
TR200000384T2 (tr) Oligonükleotitlerin çözelti fazlı sentezi.
BR9407146A (pt) Processo para beneficiamento de combustíveis por irradiação com elétrons
BR9106895A (pt) Processo com alto catalisador para detergentes de glucamida
BR0007638A (pt) Processo para determinação pós-genÈmica de estruturas atÈmicas macromoleculares
WO2001066690A3 (en) Novel compounds
WO2001072961A3 (en) Novel compounds
DE69731112D1 (de) Verfahren zur synthese von phosphorothioat-oligonukelotiden
BR9713176A (pt) Benzotiofenos amorfos,métodos de preparação e métodos de uso
DE4397266D2 (de) Spannvorrichtung für die Felle von Schlaginstrumenten
BR0114884A (pt) Compostos calcilìticos
BRPI9807312B8 (pt) derivados de (4-piperidinil)-1h-2-benzopirano úteis como agentes antipsicóticos, composição farmacêutica e processo para a preparação dos referidos derivados

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2008 DE 30/06/2009.